US Stock MarketDetailed Quotes

RF Regions Financial

Watchlist
  • 23.770
  • +0.600+2.59%
Close Dec 20 16:00 ET
  • 24.242
  • +0.472+1.99%
Post 20:01 ET
21.60BMarket Cap13.35P/E (TTM)

Regions Financial Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regions Financial Q3 2024 Earnings Date

Currency：USDOct 18, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.81B
1.79B
-15.20M
Miss Est.
-2.79%
-3.61%
-0.84%
EPS
0.52
0.49
-0.03
Miss Est.
+6.63%
--
-6.22%
Analyst Rating
Buy

Dec 16, 2024

Regions Financial Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 17, 20252025/Q1-- / 1.846B--
Jan 17, 20252024/Q4-- / 1.862B--
Oct 18, 20242024/Q31.802B / 1.805B--
Jul 19, 20242024/Q21.743B / 1.768B--
Apr 19, 20242024/Q11.760B / 1.758B--
DatePeriodRevenue/EstimateEarnings Call
Apr 17, 20252025/Q1-- / 1.846B--
Jan 17, 20252024/Q4-- / 1.862B--
Oct 18, 20242024/Q31.802B / 1.805B--
Jul 19, 20242024/Q21.743B / 1.768B--
Apr 19, 20242024/Q11.760B / 1.758B--

Unlock Free Earnings Estimates

Regions Financial Earnings Reports

  • Regions Financial | 10-Q: Q3 2024 Earnings Report

    Nov 5 12:36 ET

  • Regions Financial | 8-K: Regions reports third quarter 2024 earnings of $446 million, earnings per diluted share of $0.49

    Oct 18 06:05 ET

  • Regions Financial | 10-Q: Q2 2024 Earnings Report

    Aug 6 13:33 ET

  • Regions Financial | 8-K: Regions reports second quarter 2024 earnings of $477 million, earnings per diluted share of $0.52

    Jul 19 06:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 16, 2024

    Buy

    • Buy

      58.82%

    • Hold

      35.29%

    • Sell

      5.88%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Asset Management
    Asset Management
    Intraday+1.80%